Portal:CPTAC

From WikiPathways

Jump to: navigation, search

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

Hippo-Merlin signaling dysregulation (Homo sapiens)

Hippo-Merlin signaling dysregulation
Hippo-Merlin signaling dysregulation
Evading growth suppressors

G1 to S cell cycle control (Homo sapiens)

G1 to S cell cycle control
G1 to S cell cycle control
Activating invasion and metastasis

Integrin-mediated cell adhesion (Homo sapiens)

Integrin-mediated cell adhesion
Integrin-mediated cell adhesion
Enabling replicative immortality

lncRNA in canonical Wnt signaling and colorectal cancer (Homo sapiens)

lncRNA in canonical Wnt signaling and colorectal cancer
lncRNA in canonical Wnt signaling and colorectal cancer
Inducing angiogenesis

VEGFA-VEGFR2 signaling (Homo sapiens)

VEGFA-VEGFR2 signaling
VEGFA-VEGFR2 signaling
Resisting cell death

Apoptosis (Homo sapiens)

Apoptosis
Apoptosis
Deregulating cellular energetics

Target of rapamycin signaling (Homo sapiens)

Target of rapamycin signaling
Target of rapamycin signaling
Genome instability and mutation

Chromosomal and microsatellite instability in colorectal cancer (Homo sapiens)

Chromosomal and microsatellite instability in colorectal cancer
Chromosomal and microsatellite instability in colorectal cancer
Tumor promoting inflammation

IL-1 signaling pathway (Homo sapiens)

IL-1 signaling pathway
IL-1 signaling pathway
Avoiding immune destruction

Type II interferon signaling (Homo sapiens)

Type II interferon signaling
Type II interferon signaling
Therapeutics

Transcriptional activation by NRF2 in response to phytochemicals (Homo sapiens)

Transcriptional activation by NRF2 in response to phytochemicals
Transcriptional activation by NRF2 in response to phytochemicals

edit  

Featured Pathways

edit  

Assay Portal

CPTAC also includes an Assay Portal to widely disseminate highly characterized proteomic assays to the global research community, with access to SOPs, reagents, and assay characterization/validation data

Resources

Learn how they incorpated WikiPathways images with custom links on their site.

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools